Banner Image

today's posted documents
For Power Users
Find documents

Mayo v. Prometheus: Implications for Patents, Biotechnology, and Personalized Medicine

The recent enactment of the Leahy-Smith America Invents Act (AIA), P.L. 112-29, suggests congressional interest in patents on diagnostic methods. In particular, Section 27 of the AIA required the U.S. Patent and Trademark Office to conduct a study on the patenting of genetic diagnostic tests. The 2012 decision of the Supreme Court in Mayo Collaborative Services v. Prometheus Laboratories, Inc. also addressed these sorts of patents. The Court's decision arguably placed severe limitations on the ability of inventors to obtain diagnostic method patents.

This package includes following files:
# File Name Document Date Order ID: Number of Pages Price
1 R42815.pdf Nov 06, 2012 R42815 13 $29.95 Add to Cart

Older Versions: